Arcutis Biotherapeutics (ARQT) Proxy filing summary

Executive summary

• Annual Meeting scheduled for June 5, 2026, at 7:30 AM Pacific Time, with virtual participation available.

• Shareholders are encouraged to review proxy materials and vote by June 4, 2026.

Voting matters and shareholder proposals

• Election of three Class III directors to serve until the 2029 Annual Meeting or until successors are elected.

• Ratification of Ernst & Young LLP as independent registered public accounting firm for fiscal year ending December 31, 2026.

• Advisory vote to approve compensation of named executive officers.

• Provision to transact other business as may properly come before the meeting.

Board of directors and corporate governance

• Nominees for Class III director positions: Patrick J. Heron, Neha Krishnamohan, and Todd Franklin Watanabe.